Asset Details
Do you wish to reserve the book?
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Do you wish to request the book?
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety
2016
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Antibodies, Monoclonal, Humanized - immunology
/ Antibodies, Monoclonal, Humanized - therapeutic use
/ Antineoplastic Agents - immunology
/ Antineoplastic Agents - therapeutic use
/ Antineoplastic Combined Chemotherapy Protocols - therapeutic use
/ B7-H1 Antigen - antagonists & inhibitors
/ Female
/ Graft vs Host Disease - etiology
/ Hematopoietic Stem Cell Transplantation
/ Humans
/ Immunoconjugates - administration & dosage
/ Lung Diseases, Fungal - diagnostic imaging
/ Lung Diseases, Fungal - etiology
/ Lymphoma, Large-Cell, Anaplastic - drug therapy
/ Lymphoma, Large-Cell, Anaplastic - therapy
/ Medicine
/ Neoplasm Proteins - antagonists & inhibitors
/ Neoplasm Proteins - immunology
/ Oncology
